Cargando…

Mobilization of PBSC for allogeneic transplantation by the use of the G-CSF biosimilar XM02 in healthy donors

The human recombinant G-CSF filgrastim has been widely used for the mobilization of CD34(+) stem cells of healthy donors (HD). In 2008, the G-CSF biosimilar XM02 (Ratiograstim, Tevagrastim and Biograstim) was approved by the European Medicines Agency (EMA) for the mobilization of PBSC. However, ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmitt, M, Xu, X, Hilgendorf, I, Schneider, C, Borchert, K, Gläser, D, Freund, M, Schmitt, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3701262/ https://www.ncbi.nlm.nih.gov/pubmed/23318540 http://dx.doi.org/10.1038/bmt.2012.270

Ejemplares similares

Biosimilar G-CSF Based Mobilization of Peripheral Blood Hematopoietic Stem Cells for Autologous and Allogeneic Stem Cell Transplantation
por: Schmitt, Michael, et al.
Publicado: (2014)

Evaluation of a biosimilar granulocyte colony-stimulating factor (filgrastim XM02) for peripheral blood stem cell mobilization and transplantation: a single center experience in Japan
por: Yoshimura, Hideaki, et al.
Publicado: (2017)

Graft-vs-tumor effect in patients with advanced nasopharyngeal cancer treated with nonmyeloablative allogeneic PBSC transplantation
por: Toh, H C, et al.
Publicado: (2011)

High proportions of regulatory T cells in PBSC grafts predict improved survival after allogeneic haematopoietic SCT
por: Danby, R D, et al.
Publicado: (2016)

Myeloablative Conditioning with PBSC Grafts for T Cell-Replete Haploidentical Donor Transplantation Using Posttransplant Cyclophosphamide
por: Solomon, Scott R., et al.
Publicado: (2016)

Impact of Cryopreservation of Peripheral Blood Stem Cells (PBSC) in Transplantation from Matched Unrelated Donor (MUD)
por: Facchin, Gabriele, et al.
Publicado: (2022)

Biosimilar G-CSF versus filgrastim and lenograstim in healthy unrelated volunteer hematopoietic stem cell donors
por: Farhan, Roiya, et al.
Publicado: (2017)

Olivetti OPE XM 5220/2
Publicado: (2017)

Production of xylitol and bio-detoxification of cocoa pod husk hemicellulose hydrolysate by Candida boidinii XM02G
por: Santana, Nivio Batista, et al.
Publicado: (2018)

Human Regulatory T Cells of G-CSF Mobilized Allogeneic Stem Cell Donors Qualify for Clinical Application
por: Ukena, Sya N., et al.
Publicado: (2012)

AVT02: An Adalimumab Biosimilar
por: Kang, Connie
Publicado: (2022)

Filgrastim XM02 (Tevagrastim®) after autologous stem cell transplantation compared to lenograstim: favourable cost-efficacy analysis
por: Gardellini, A, et al.
Publicado: (2013)

Immune Responses to RHAMM in Patients with Acute Myeloid Leukemia after Chemotherapy and Allogeneic Stem Cell Transplantation
por: Casalegno-Garduño, R., et al.
Publicado: (2012)

Biosimilar granulocyte–colony-stimulating factor for healthy donor stem cell mobilization: need we be afraid?
por: Bonig, Halvard, et al.
Publicado: (2015)

Correction to: AVT02: An Adalimumab Biosimilar
por: Kang, Connie
Publicado: (2022)

Assessment of Neutrophil Chemotaxis Upon G-CSF Treatment of Healthy Stem Cell Donors and in Allogeneic Transplant Recipients
por: Thunström Salzer, Anna, et al.
Publicado: (2018)

Commentary: Autologous Peripheral Blood Stem Cells (PBSC) are Safe and Effective in Knee Osteoarthritis
por: Papadopoulos, Konstantinos I., et al.
Publicado: (2021)

AN INHERITED X-LINKED SERUM SYSTEM IN MAN : THE XM SYSTEM
por: Berg, Kåre, et al.
Publicado: (1966)

Optimal ex vivo expansion of neutrophils from PBSC CD34(+ )cells by a combination of SCF, Flt3-L and G-CSF and its inhibition by further addition of TPO
por: Tura, Olga, et al.
Publicado: (2007)

Presently available biosimilars in hematology-oncology: G-CSF
por: Gascon, Pere
Publicado: (2012)

Use of Biosimilar Granulocyte Colony-Stimulating Factor for Mobilization in Autologous and Allogeneic Hematopoietic Stem Cell Transplantation
por: Eplin, Dwight D., et al.
Publicado: (2019)

Addition of plerixafor in poorly mobilized allogeneic stem cell donors
por: Zhuang, Lefan, et al.
Publicado: (2022)

Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation?
por: Li, Jiali, et al.
Publicado: (2020)

Structure of Vibrio Phage XM1, a Simple Contractile DNA Injection Machine
por: Wang, Zhiqing, et al.
Publicado: (2023)

XM02 is superior to placebo and equivalent to Neupogen™ in reducing the duration of severe neutropenia and the incidence of febrile neutropenia in cycle 1 in breast cancer patients receiving docetaxel/doxorubicin chemotherapy
por: del Giglio, A, et al.
Publicado: (2008)

Antithymocyte globulin administration in patients with profound lymphopenia receiving a PBSC purine analog/busulfan-based conditioning regimen allograft
por: Jullien, Maxime, et al.
Publicado: (2020)

Involvement of the capsular GalXM-induced IL-17 cytokine in the control of Cryptococcus neoformans infection
por: LaRocque-de-Freitas, Isabel Ferreira, et al.
Publicado: (2018)

Impaired Functionality of Antiviral T Cells in G-CSF Mobilized Stem Cell Donors: Implications for the Selection of CTL Donor
por: Bunse, Carola E., et al.
Publicado: (2013)

Predicting Successful Hematopoietic Stem Cell Collection in Healthy Allogeneic Donors
por: Kayser, Sabine, et al.
Publicado: (2023)

Phase 1 safety, tolerability, and pharmacokinetic study of single ascending doses of XM17 (recombinant human follicle-stimulating hormone) in downregulated healthy women
por: Lammerich, Andreas, et al.
Publicado: (2015)

Draft Genome Sequence of Loktanella cinnabarina Strain XM1 Isolated from Coastal Surface Water
por: Ma, Ruijie, et al.
Publicado: (2017)

PW02-033 - Cytokine profile in CSF in CAPS patients
por: Schuh, E, et al.
Publicado: (2013)

Pooled analysis of three pharmacokinetic studies comparing biosimilar MB02 and reference bevacizumab
por: Miguel‐Lillo, B., et al.
Publicado: (2023)

The signal peptide-like segment of hpaXm is required for its association to the cell wall in transgenic tobacco plants
por: Li, Le, et al.
Publicado: (2017)

Complete Genome Sequence of Magnetospirillum sp. Strain XM-1, Isolated from the Xi’an City Moat, China
por: Wang, Yinzhao, et al.
Publicado: (2016)

Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap(®) (XM17), Comparability with Gonal-f(®), and Performance/Consistency
por: Winstel, Rainer, et al.
Publicado: (2017)

Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia
por: Fan, Qian, et al.
Publicado: (2017)

A randomized, single-dose, pharmacokinetic equivalence study comparing MB02 (proposed biosimilar) and reference bevacizumab in healthy Japanese male volunteers
por: Eto, Takashi, et al.
Publicado: (2021)

Leukemia cell mobilization with G-CSF plus plerixafor during busulfan-fludarabine conditioning in allogeneic stem cell transplantation
por: Konopleva, Marina, et al.
Publicado: (2015)

G-CSF-induced severe thrombocytopenia in a healthy donor: A rare case report
por: Lu, Xuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rdq6hu0bj9ueo3euhogfum0lmv